Your Cart ( 1 Item )

• Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years
  August 2018 | Volume 17 | Issue 8 | Original Article | 826 | Copyright © August 2018
  Christopher E.M. Griffiths MD,^a Kim A. Papp MD,^b Alexa B. Kimball MD,^c Bruce Randazzo MD,^d Michael Song MD,^d Shu Li PhD,^d Yaung-Kaung Shen PhD,^d Andrew Blauvelt MD^e
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs